Interview with Eric Blondeau, Managing Director, Alliance Healthcare Russia
You took over this organization just three months ago, having previously headed businesses in industries as diverse…
Alliance Healthcare Russia
Last updated: 13.02.2014
Address: 109383,г. Москва, Ул. Песчаный карьер, дом 3, стр. 1,Russia
Tel: +7 (495) 287-77-00
Web: http://www.alliance-healthcare.ru/
Company description
Alliance Healthcare Russia is a Russian national pharmaceutical distributor and a part of the international pharmaceutical Alliance Boots Group which is the European leader in pharmacy-led health and beauty.
Alliance Healthcare Russia has 65 branches and representative offices. The company has stable position among Russian leading pharmaceutical distributors.
The project Alloga is currently being developed actively in providing customers with pre-distribution services. In October 2010 the warehouse in Klimovsk (Moscow area) was opened. This is one of the biggest and equipped warehouses all over Europe. It complies with the strictest international standards.
About three years ago one of successful European projects Alphega Pharmacy was launched. It was established in 2001 and by now membership has reached 3700 participants, they are independent pharmacies in six countries: Great Britain, France, Spain, Czech, Italy. Russia joined the organization in 2008. In total almost 600 pharmacies gathered under the brand Alphega Pharmacy in Russia.
Alliance Healthcare Russia is developing actively its key operations in pharmaceutical distribution as well as considers an opportunity of launch in Russia of completely new brands of products and services which are world-wide recognized and owned by Alliance Boots.
Products and services
Distribution and retail of pharmaceutical products throughout the Russian territory.
Interviews
Related
Sputnik V / A Brief History of Russia’s Controversial Viral Vector COVID-19 Vaccine
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion…
Russia / Biocad Ramps up Sputnik V Manufacturing; Unlicensed Remdesivir Generics; Chinese Vaccine Rejection
The latest Russia Pharma News, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…
Russia / $7.4 bln for Healthcare Modernisation; Generics Push; Sputnik Vaccine Successes
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…
COVID-19 / Russia First Mover in Approving Vaccine Amid Widespread Criticism
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities,…
News Roundup / Russian Pharma: April 2020
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in…
Drug Shortages / An Increasing Concern in Russia
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening…
Russian bots targeted US and vaccines
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has…
Interview with Arman Voskertchyan, Managing Director, Johnson & Johnson…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this…
Interview with Eric Blondeau, Managing Director, Alliance Healthcare Russia
You took over this organization just three months ago, having previously headed businesses in industries as diverse…
Interview with Victor Dmitriev, General Director, Association of the Russian…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the…
Interview with Vladimir Shipkov, Executive Director, Association of…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of…
Interview with Andrew Somers, President & CEO, American Chamber of Commerce…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of…
